Skip to main content
Premium Trial:

Request an Annual Quote

Marvin Cassman, David Haussler, Janet Thornton, Gregory Sessler

Premium

Marvin Cassman has been appointed director of the Institute for Quantitative Biomedical Research (QB3), a new multi-campus effort based at the University of California, San Francisco, with additional facilities planned for UC’s Berkeley and Santa Cruz campuses.

Cassman is currently director of the National Institute of General Medical Sciences of the NIH. As director of the QB3 Institute, Cassman will “oversee innovative programs designed to integrate physical, mathematical, and engineering sciences to create powerful new techniques for attacking biological problems,” according to a QB3 statement.

The institute will be organized around three research and education modules: bioengineering and biotechnology, bioinformatics, and structural and chemical biology. It will focus on “developing techniques for storing and analyzing vast quantities of biological information and using imaging and mathematical modeling to view molecules, cells, and single organ systems as part of functional networks.”

David Haussler will direct QB3 efforts at the UC Santa Cruz campus.

 

Janet Thornton, director of the European Bioinformatics Institute, was honored last week for her work in protein structure modeling and analysis. Giving the Feodor Lynen Lecture at the Nature Biotechnology Winter Symposium in Miami, Fla., Thornton spoke about the need to identify the “druggable proteome.”

Among numerous other honors, Thornton was made a Commander of the British Empire last year.

 

Seattle-based Icogen has appointed Gregory Sessler, former senior vice president and chief financial officer of Rosetta Inpharmatics, to its board of directors.

Filed under

The Scan

Rare Genetic Disease Partnership

A public-private partnership plans to speed the development of gene therapies for rare genetic diseases, Stat News writes.

Approval Sought for Alzheimer's Drug

The Wall Street Journal reports Eli Lilly has initiated a rolling submission to the US Food and Drug Administration to seek approval for its drug to treat Alzheimer's disease.

DNA Barcoding Paper Retracted

Science reports that a 2014 DNA barcoding paper was retracted after a co-author brought up data validity concerns.

Nature Papers Present Genomic Analysis of Bronze Age Mummies, Approach to Study Host-Pathogen Interactions

In Nature this week: analysis finds Tarim mummies had local genetic origin, and more.